Jeffrey R. Curtis

46.9k total citations · 5 hit papers
684 papers, 25.1k citations indexed

About

Jeffrey R. Curtis is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Jeffrey R. Curtis has authored 684 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 408 papers in Rheumatology, 118 papers in Immunology and 107 papers in Hematology. Recurrent topics in Jeffrey R. Curtis's work include Rheumatoid Arthritis Research and Therapies (353 papers), Systemic Lupus Erythematosus Research (148 papers) and Autoimmune and Inflammatory Disorders Research (106 papers). Jeffrey R. Curtis is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (353 papers), Systemic Lupus Erythematosus Research (148 papers) and Autoimmune and Inflammatory Disorders Research (106 papers). Jeffrey R. Curtis collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey R. Curtis's co-authors include Kenneth G. Saag, Elizabeth Delzell, Fenglong Xie, Lang Chen, Huifeng Yun, Kevin Winthrop, Nicole C. Wright, Ted R. Mikuls, Daniel H. Solomon and Nivedita M. Patkar and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

Jeffrey R. Curtis

658 papers receiving 24.5k citations

Hit Papers

The Recent Prevalence of ... 2004 2026 2011 2018 2014 2004 2010 2017 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
    2014 1.3k citations Kenneth G. Saag, Jeffrey R. Curtis et al. Journal of Bone and Mineral Research profile →
  2. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study
    2004 578 citations Jeffrey R. Curtis, Ted R. Mikuls et al. profile →
  3. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
    2010 516 citations Liron Caplan, Jeffrey R. Curtis et al. Arthritis Care & Research profile →
  4. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
    2017 302 citations Jeffrey R. Curtis, Eun Bong Lee et al. Annals of the Rheumatic Diseases profile →
  5. Risk of subsequent fracture after prior fracture among older women
    2018 224 citations Jeffrey R. Curtis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey R. Curtis United States 79 11.3k 4.4k 4.2k 4.1k 4.0k 684 25.1k
Daniel H. Solomon United States 96 13.5k 1.2× 7.5k 1.7× 5.7k 1.4× 2.8k 0.7× 4.1k 1.0× 585 36.0k
Cynthia S. Crowson United States 87 13.7k 1.2× 4.7k 1.1× 1.6k 0.4× 2.7k 0.6× 4.3k 1.1× 476 28.1k
Sherine E. Gabriel United States 76 16.4k 1.5× 5.3k 1.2× 1.2k 0.3× 3.2k 0.8× 4.1k 1.0× 202 29.3k
Tore K Kvien Norway 84 18.4k 1.6× 3.8k 0.9× 1.8k 0.4× 5.4k 1.3× 5.5k 1.4× 537 28.6k
Kenneth G. Saag United States 86 7.4k 0.7× 6.0k 1.4× 8.6k 2.1× 2.5k 0.6× 1.8k 0.5× 476 26.7k
Maxime Dougados France 83 18.9k 1.7× 3.9k 0.9× 2.4k 0.6× 5.4k 1.3× 6.4k 1.6× 395 24.8k
Mark Lunt United Kingdom 70 7.0k 0.6× 2.5k 0.6× 1.4k 0.3× 2.6k 0.6× 3.4k 0.8× 353 15.9k
Maxime Dougados France 74 19.5k 1.7× 1.4k 0.3× 2.2k 0.5× 6.9k 1.7× 9.4k 2.3× 546 23.9k
Robert Landewé Netherlands 83 20.5k 1.8× 1.5k 0.3× 2.6k 0.6× 6.7k 1.6× 8.8k 2.2× 532 25.0k
Hyon K. Choi United States 95 15.6k 1.4× 9.0k 2.0× 1.2k 0.3× 2.1k 0.5× 3.8k 0.9× 405 38.3k

Countries citing papers authored by Jeffrey R. Curtis

Since Specialization
Citations

This map shows the geographic impact of Jeffrey R. Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey R. Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey R. Curtis more than expected).

Fields of papers citing papers by Jeffrey R. Curtis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey R. Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey R. Curtis. The network helps show where Jeffrey R. Curtis may publish in the future.

Co-authorship network of co-authors of Jeffrey R. Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey R. Curtis. A scholar is included among the top collaborators of Jeffrey R. Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey R. Curtis. Jeffrey R. Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
England, Bryant R., Joshua F. Baker, Michael George, et al.. (2025). Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study. The Lancet Rheumatology. 7(3). e166–e177. 4 indexed citations
2.
3.
Jannat‐Khah, Deanna, Fenglong Xie, Ashish Saxena, Jeffrey R. Curtis, & Anne R. Bass. (2025). Survival in Immune Checkpoint Inhibitor–Treated Patients With Rheumatoid Arthritis and Non–Small Cell Lung Cancer: An Observational Cohort Study. Arthritis Care & Research. 77(10). 1214–1221.
4.
Choi, Yunhee, et al.. (2024). Modeling of antibody responses to COVID-19 vaccination in patients with rheumatoid arthritis. Scientific Reports. 14(1). 1335–1335.
5.
Mannion, Melissa L., Fenglong Xie, John FitzGerald, et al.. (2024). Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States. Arthritis & Rheumatology. 76(7). 1153–1161. 2 indexed citations
6.
Nowell, W. Benjamin, Kelly Gavigan, Kimberly B. Garza, et al.. (2024). Which Educational Topics and Smartphone App Functions Are Prioritized by US Patients With Rheumatic and Musculoskeletal Diseases? A Mixed-Methods Study. The Journal of Rheumatology. 51(9). 904–912. 2 indexed citations
7.
Deodhar, Atul, Servet Akar, Jeffrey R. Curtis, et al.. (2024). Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis. Advances in Rheumatology. 64(1). 87–87. 1 indexed citations
8.
Mudano, Amy S., Fenglong Xie, Jingyi Zhang, et al.. (2024). Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation. Arthritis Research & Therapy. 26(1). 86–86.
9.
10.
Roul, Punyasha, Yangyuna Yang, Tate Johnson, et al.. (2023). Multimorbidity Patterns and Rheumatoid Arthritis Disease Outcomes: Findings From a Multicenter, Prospective Cohort. Arthritis Care & Research. 77(3). 337–348. 7 indexed citations
11.
Qu, Haiyan, Stuart L. Silverman, Richard M. Shewchuk, et al.. (2022). Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach. Risk Management and Healthcare Policy. Volume 15. 1293–1302.
12.
Friedman, Marcia, Jeffrey R. Curtis, & Kevin Winthrop. (2021). Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases. 80(10). 1255–1265. 71 indexed citations
13.
Curtis, Jeffrey R., Cecilie Heegaard Brahe, Mikkel Østergaard, et al.. (2019). Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies. Current Medical Research and Opinion. 35(9). 1483–1493. 15 indexed citations
14.
Lillegraven, Siri, Jeffrey D. Greenberg, George Reed, et al.. (2019). Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis. PLoS ONE. 14(1). e0210459–e0210459. 39 indexed citations
15.
Boers, Maarten, Jasvinder A. Singh, Stacey S. Cofield, et al.. (2018). A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials. Arthritis Care & Research. 71(2). 319–322. 3 indexed citations
16.
Cannon, Grant W., Ted R. Mikuls, Jian Ying, et al.. (2011). Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. Arthritis Care & Research. 63(12). 1680–1690. 79 indexed citations
17.
Zhang, Jie, Ying Shan, George Reed, et al.. (2011). Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort. Arthritis Care & Research. 63(12). 1672–1679. 42 indexed citations
18.
Schiff, Michael, Edward Keystone, Tore K Kvien, et al.. (2010). The Efficacy of Certolizumab Pegol Added to Methotrexate is Sustained Over 2 Years in the Treatment of Rheumatoid Arthritis. The Journal of Rheumatology. 37(6). 1332–1332. 8 indexed citations
19.
Warriner, Amy H. & Jeffrey R. Curtis. (2009). Adherence to osteoporosis treatments: room for improvement. Current Opinion in Rheumatology. 21(4). 356–362. 51 indexed citations
20.
Curtis, Jeffrey R., Andrew O. Westfall, Hong Cheng, et al.. (2008). Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users. Journal of Bone and Mineral Research. 23(9). 1435–1441. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by Cynthia S. Crowson Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by Tore K Kvien Breakdown of academic impact, for papers by Kenneth G. Saag Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Mark Lunt Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Robert Landewé Breakdown of academic impact, for papers by Hyon K. Choi
Rankless by CCL
2026